The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DELFI-L101: Development of a blood-based assay that evaluates cell-free DNA fragmentation patterns to detect lung cancer.
 
Peter J. Mazzone
Consulting or Advisory Role - Delfi Diagnostics (Inst); Nucleix (Inst); Veracyte (Inst)
Research Funding - Biodesix (Inst); Delfi Diagnostics (Inst); Exact Sciences (Inst); MagArray (Inst); Nucleix (Inst); PrognomIQ (Inst); Veracyte (Inst)
 
Kyle Work
Research Funding - Delfi Diagnostics; Seagen
 
Victor E. Velculescu
Leadership - Delfi Diagnostics; Personal Genome Diagnostics
Stock and Other Ownership Interests - Delfi Diagnostics; Personal Genome Diagnostics
Consulting or Advisory Role - Bristol-Meyers Squibb; Danaher; Delfi Diagnostics; Genentech; Ignyta; Merck; Personal Genome Diagnostics; Takeda
Research Funding - Delfi Diagnostics
Patents, Royalties, Other Intellectual Property - Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Agios.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Delfi Diagnostics.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Genzyme.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Myriad.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Personal Genome Diagnostics.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Qiagen.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Roche.; Receive royalties for discoveries our group has made at Johns Hopkins that have been licensed by Sysmex-Inostics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Delfi Diagnostics; Genentech
 
Sonali Kotagiri
Employment - Delfi Diagnostics; Natera
Stock and Other Ownership Interests - Delfi Diagnostics; Natera
 
Lee Ming Sun
Employment - Delfi Diagnostics; Gilead Sciences
Stock and Other Ownership Interests - Delfi Diagnostics; Gilead Sciences
 
Daniel Dix
Employment - Delfi Diagnostics
Stock and Other Ownership Interests - Delfi Diagnostics; Guardant Health
 
Debbie M Jakubowski
Employment - Delfi Diagnostics; Exact Sciences
Stock and Other Ownership Interests - Delfi Diagnostics; Exact Sciences
 
Alessandro Leal
Employment - Delfi Diagnostics
Stock and Other Ownership Interests - Delfi Diagnostics
Honoraria - Amgen; AstraZeneca; Libbs; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Delfi Diagnostics
Speakers' Bureau - Oncologia Brasil
Patents, Royalties, Other Intellectual Property - Delfi Diagnostics
Travel, Accommodations, Expenses - Delfi Diagnostics
 
Peter Brian Bach
Leadership - Delfi Diagnostics; Oncology Analytics
Stock and Other Ownership Interests - Delfi Diagnostics; EQRx; Oncology Analytics
Consulting or Advisory Role - EQRx
Research Funding - Kaiser Permanente; Laura and John Arnold Foundation; NIH
Travel, Accommodations, Expenses - Oncology Analytics
 
Tara Maddala
Employment - Delfi Diagnostics
Stock and Other Ownership Interests - Delfi Diagnostics; Illumina
Consulting or Advisory Role - GRAIL